Medirom Healthcare Technologies Inc

Aktienanalyse zu Medirom Healthcare Technologies Inc (MRM)

$0.284

-0.004 (-1.46%)Zum Schluss

Loading chart…
Hoch
0.300
Eröffnung
0.300
Volumengewichteter Durchschnittskurs
0.29
Volumen
13.98K
Marktkap.
18.55M
Tief
0.280
Umsatz
4.03K
EV/EBITDA, TTM
0.00

Medirom Healthcare Technologies Inc is a Japan-based holistic health services provider. The Company is a franchiser and operator of healthcare salons across Japan and is a preferred platform partner for large consumer brands, healthcare service providers and government entities. The Company mainly operates in two business segments. The Relaxation Salon Segment is engaged in the development of relaxation studios nationwide, centered on Re.Ra.Ku for the purpose of health management services. The Digital Preventative Healthcare Segment is involved in the sampling business, which includes brand promotion and consumer analysis for third party brands of corporate clients, government-sponsored specific health guidance program, utilizing internally-developed on-demand health monitoring smartphone application Lav, as well as MOTHER Tracker for fitness applications, and preventative healthcare services utilizing digital application and devices.

medirom.co.jp

KI-Analyse of Medirom Healthcare Technologies Inc (MRM)

Verkaufen

Medirom Healthcare Technologies Inc (MRM) is not a good buy right now due to its extremely low RSI of 12.99, indicating it is oversold, and a staggering year-to-date change of -85.49%. The company's gross margin has improved to 99.65% in the last quarter, but the overall financial health is concerning with a debt-to-equity ratio of 174.83% and a current ratio of only 1.75, suggesting liquidity issues. The main risk is the significant decline in stock price, which has dropped 48.57% over the last 20 days, indicating a lack of investor confidence and potential further declines.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Medirom Healthcare Technologies Inc (MRM) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von 0.00.

Erwartetes KGV

Stark unterbewertet
5J-Durchschnitt P/E
0.00
Aktuelles P/E
0.00
Überbewertet
0.00
Unterbewertet
0.00

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
2.75
Aktuelles EV/EBITDA
0.00
Überbewertet
7.92
Unterbewertet
-2.42

Erwartetes KUV

Fair bewertet
5J-Durchschnitt P/S
0.04
Aktuelles P/S
0.00
Überbewertet
0.14
Unterbewertet
-0.05

Alphio-AI-Kursszenarien für MRM

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%MRM

$1.40

Szenariopreis

B

Basis

Basis · 50%MRM

$1.32

Szenariopreis

B

Bärisch

Bärisch · 25%MRM

$1.07

Szenariopreis

Event-Zeitleiste

2026-02-27 (ET)

08:10:00

Medirom Healthcare Signs Agreement with Tools for Humanity, Projects $39 Million Income Over Two Years

2025-12-29 (ET)

08:30:00

MEDIROM Collaborates with World Foundation to Deploy Proof of Human Technology in Japan

2025-12-26 (ET)

18:00:00

Medirom Healthcare Partners with World Foundation to Deploy Proof of Human Technology

2025-10-29 (ET)

10:25:23

Medirom Healthcare to Introduce New Treasury Strategy Utilizing Cryptocurrency

2025-10-28 (ET)

08:36:02

Medirom Healthcare reports that more than 10,000 individuals have obtained World IDs at various locations.

News

MRM FAQ – beantwortet von Alphio AI

Medirom Healthcare Technologies Inc is a Japan-based holistic health services provider. The Company is a franchiser and operator of healthcare salons across Japan and is a preferred platform partner for large consumer brands, healthcare service providers and government entities. The Company mainly operates in two business segments. The Relaxation Salon Segment is engaged in the development of relaxation studios nationwide, centered on Re.Ra.Ku for the purpose of health management services. The Digital Preventative Healthcare Segment is involved in the sampling business, which includes brand promotion and consumer analysis for third party brands of corporate clients, government-sponsored specific health guidance program, utilizing internally-developed on-demand health monitoring smartphone application Lav, as well as MOTHER Tracker for fitness applications, and preventative healthcare services utilizing digital application and devices. It operates in the Consumer Non-Cyclicals sector.

Medirom Healthcare Technologies Inc (MRM) is not a good buy right now due to its extremely low RSI of 12.99, indicating it is oversold, and a staggering year-to-date change of -85.49%. The company's gross margin has improved to 99.65% in the last quarter, but the overall financial health is concerning with a debt-to-equity ratio of 174.83% and a current ratio of only 1.75, suggesting liquidity issues. The main risk is the significant decline in stock price, which has dropped 48.57% over the last 20 days, indicating a lack of investor confidence and potential further declines.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln